Lykos’ MDMA Heads To AdComm With US FDA Concerns About Adverse Event Reporting

 
• By Bridget Silverman
  
head shape with PTSD
• Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers